Last updated on 11 Jan 2023
Owner Info
Taro Pharmaceuticals U.S.A., Inc.
3 Skyline Drive
Hawthorne NY 10532, UNITED STATES OF AMERICA
Serial Number
2280224 filed on 27 May 2022
Correspondent
Camille M. Miller
Cozen O'Connor,,
1650 Market Street, Suite 2800,
UNITED STATES OF AMERICA
2280224
27 May 2022
27 May 2032
FIGURATIVE, FANCY
23 May 2022
US
Status Date | Action Taken |
---|---|
11th Jan 2023 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
10th Jan 2023 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
10th Jan 2023 | IP Right Registration Published |
10th Jan 2023 | Status change to Registered/Protected |
24th Oct 2022 | Application Accepted correspondence sent |
24th Oct 2022 | Application Accepted correspondence sent |
24th Oct 2022 | IP Right has been Examined |
24th Oct 2022 | IP Right Acceptance Published |
20th Sept 2022 | Early Acceptance Notice correspondence sent |
20th Sept 2022 | Status change to Accepted |